April 26 (Reuters) - Mead Johnson Nutrition Co raised its 2012 forecast as strength in China and Latin America helped offset a dent in its U.S. business from a contamination scare, sending the Enfamil baby formula maker's shares up 4 percent.
April 26 (Reuters) - Mead Johnson Nutrition Co , the maker of Enfamil baby formula, raised its 2012 forecast as it reported higher quarterly profit and sales on Thursday.
Mead Johnson Nutrition ( MJN ): Q1 EPS of $0.82 beats by $0.04 . Revenue of $986M (+9.6% Y/Y) beats by $9M . ( PR ) Post your comment!
reflects the fact that Nestle wanted to keep this valuable asset out of its competitors' hands (namely Danone BN and Mead Johnson MJN ). From Pfizer's perspective, while Pfizer sold the nutrition unit for a slightly higher than expected price
Danone ( DANOY.PK -2.3% ), bidding along with Mead Johnson ( MJN +1.8% ), reportedly raises its offer for Pfizer's ( PFE +1.2% ) infant nutrition business to nearly $11B. Analysts
nutrition units. One possible buyer for the nutrition business is the French company Danone, and another is Mead Johnson Nutrition ( MJN ), which could bid $10 billion. Pfizer's animal health unit could also receive a bid of up to $18 billion
estimated value . However, with the bids likely to face regulatory hurdles, Nestle is said to be considering making asset sales as part of any deal, while Danone is reportedly considering a joint bid with Mead Johnson ( MJN ). Post your comment!
Bancroft took over Bristol's top posts, replacing James Cornelius as CEO and Marc Huet as CFO, respectively. While ..... Bristol's divestiture of its nutritional business Mead Johnson MJN , through a spin-off in late 2009, reduced the
(Reuters) - Mead Johnson Nutrition Co , the maker of Enfamil baby formula, posted a slightly higher-than-expected quarterly profit but said a contamination scare could mean lower market share at...
Good day, ladies and gentlemen, and welcome to the Mead Johnson Nutrition Fourth Quarter 2011 Earnings Conference Call. My ..... purposes. Thank you, and good morning. Welcome to Mead Johnson 's fourth quarter conference call. With me today